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Abstract  
  
Prostate cancer (PCa) is the second most common cancer in men worldwide, however the prevalence 
in developed countries is significantly higher than in developing countries. In Australia prostate cancer 
is expected to be the most common cancer diagnosed in 2017, as one in five men are at risk of 
developing prostate cancer before 85 years of age. While the five-year survival for prostate cancer is 
at 95%, men in rural or regional areas have a 20% lower survival rate than those residing in the major 
cities. The high rate of diagnosis in developed countries, including Australia, has been linked to 
lifestyle, specifically diet. The Western diet is typically high in refined carbohydrates, fat and red meat 
and this diet has been shown to cause inflammation in various tissues. Inflammation in the prostate 
gland has been linked to the development of precancerous states and eventually cancer. Furthermore, 
alterations in gene expression pathways in the prostate in response to the inflammatory state are also 
associated with cancer progression. Capsaicin, a dietary phytochemical from chilli, has been shown to 
have anti-cancer and anti-inflammatory properties. The effectiveness of capsaicin dietary 
supplementation in preventing or reducing the inflammation and cancer-causing gene expression 
changes induced by a high carbohydrate and high fat diet has not been explored in the prostate gland.  
If effective, this may represent an inexpensive mechanism for men, living in both cities and in regional 
areas to decrease their risk of developing prostate cancer by supplementing their diet with capsaicin.     
This study investigated the effect of a Western diet and the addition of capsaicin to the diet on gene 
expression in tumourigenic and inflammatory pathways. In response to the diet, the expression of the 
transient receptor potential vanilloid 6 (TRPV6) was significantly increased, a response that was 
prevented in the capsaicin treated rats receiving the same diet.  Additionally, the histomorphology of 
the prostate demonstrated early abnormal cellular changes, with increased epithelial cell height and 
reduced glandular infolding.  
These results suggests that after the treatment period the Western diet has induced molecular and 
cellular changes resulting in early alterations in cell function and appearance. The prevention of the 
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increased expression of TRPV6, suggests that the addition of capsaicin to the diet may be able to 
prevent changes associated with tumourigenesis. Further exploration into the effects of capsaicin in 
the prostate and the ability to prevent pre-cancerous stages are recommended.   
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Chapter 1: Introduction and literature review  
  
1.1 Prostate cancer incidence and mortality  
  
Cancer is a significant burden in developed, developing and undeveloped regions worldwide, with 
approximately 14.1 million cancer diagnoses and 8.2 million cancer related deaths in 2012. Prostate 
cancer (PCa) is the second leading cancer diagnosed and the fifth highest cause of cancer related death 
globally. In developed or so-called Western countries including Australia, United States, United 
Kingdom, Canada, New Zealand, Argentina, Chile and most European countries, the incidence of PCa 
is even greater (Torre et al. 2015). In Australia, it is estimated that in 2017 PCa will be the most 
common cancer, with one in five men diagnosed and is the second leading cause of cancer related 
deaths (Australian Institute of Health and Welfare 2017a). In 2011 it was the third highest cause of 
cancer burden in Australia, particularly among those aged 65 years and older (Australian Institute of 
Health and Welfare 2017b). The use of prostate specific antigen (PSA) screening for PCa has resulted 
in an increase in diagnosis and reduction of mortality from the disease, a trend also seen in Australia 
with a 95% five year survival rate in men diagnosed with PCa, although mortality is higher in rural and 
regional communities with a 20% lower survival rate reported (Australian Institute of Health and 
Welfare 2017a; Schröder et al. 2009). The health care cost of PCa in Australia in 2008-2009 was 
approximately $349 million, 16% of the total cost of cancer related health care (Australian Institute of 
Health and Welfare 2013). There is no single cause of prostate cancer however the greater incidence 
of PCa in developed countries has been linked to increasing rates of obesity, the Western diet and an 
inactive lifestyle (Center et al. 2012). Although higher rates of diagnosis in Western countries can be 
partially attributed to the implementation of PSA testing detecting more cancers that would have 
previously gone undiagnosed, the Western diet also appears to be a major factor (Kimura 2012). 
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1.2 Prostate gland biology   
  
The prostate is a gland located inferior to the urinary bladder, encircling the urethra. In humans, the 
prostate has three sets of ducts that serve three regions called the central, transition and peripheral 
zones. The morphology of the prostate gland in rodents differs from the human as it has distinct 
anterior and ventral lobes (Cunha et al. 2004). The gland is composed of an epithelium, consisting of 
basal cells, luminal tall columnar cells (secretory cells) and neuroendocrine cells, and supportive 
stroma formed from connective tissue, immune cells and blood vessels as shown in Figure 1 (Krušlin, 
Ulamec & Tomas 2015). The androgen hormones, testosterone and the more active 
dihydrotestosterone, bind to the androgen receptor (AR) which then regulates the expression of genes 
necessary for prostate function (Koochekpour 2010). Prostate cell survival and proliferation is 
dependent on AR signalling (Chang et al. 2013). The physiological function of the prostate is to produce 
a fluid added to semen, containing proteins, including prostate specific antigen (PSA), zinc and sugars 
(Murashima et al. 2015).    
 
Figure 1: Normal and cancerous prostate gland (Rane, Pellacani & Maitland 2012)  
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1.3 Prostate cancer tumourigenesis  
  
Cancer is the uncontrolled proliferation of malignant cells which are resistant to programmed cell 
death (apoptosis). Malignancy in cancer cells is initiated by a series of genetic mutations or alterations 
in gene expression (epigenetics) causing downregulation of tumour suppressor genes, and 
upregulation of oncogenes (genes promoting tumour growth). These changes facilitate the growth of 
cancer within its tissue of origin and as the cancer cells undergo further mutations, they gain the ability 
to invade nearby tissue, blood vessels and lymph nodes and metastasise (spread) throughout the body 
(Hanahan & Weinberg 2011; Sarkar et al. 2013).   
Most often, PCa arises in the epithelium, which is composed of basal cells, luminal cells and 
neuroendocrine cells (Lee & Shen 2015). Cancer arising in the luminal cells are termed acinar 
adenocarcinomas and this is the most common form of PCa (Stoyanova et al. 2013).  
 
Figure 2: Progression of normal prostate to precancerous state to cancer (Packer & Maitland 2016)  
  
The development of PCa is preceded by changes in the prostate tissue, referred to as proliferative 
inflammatory atrophy (PIA) and prostatic intraepithelial neoplasia (PIN) as illustrated in Figure 2. These 
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changes typically occur in the same area of tissue that most PCas occur, in the luminal cells of the 
peripheral zone (Packer & Maitland 2016).  The characteristics of PIA include focal lesions of 
inflammation in the epithelium containing cells that are abnormally reduced in size (atrophic) and are 
undergoing increased proliferation. Inflammation is a key factor in the development of PIA, and 
greater severity of inflammation is strongly associated with increasing incidence of these focal lesions 
(Benedetti, Bettin & Reyes 2016). The presence of PIA lesions in prostate biopsies has been associated 
with an increased risk of PCa development and an increased risk of death, suggesting an association 
between both inflammation and increased proliferation of atrophic cells, and PCa (Davidsson et al. 
2011; Kryvenko et al. 2012). Other cellular changes include oxidative stress and alterations in gene 
expression which are associated with carcinogenesis (cancer development). The gene coding for NK3 
homeobox 1 (NKX3.1) protein is affected in the majority of early PCa, with one allele being deleted 
resulting in reduced protein production (Bethel et al. 2006). NKX3.1 is primarily expressed in the 
prostate in both humans and rodents and as a homeobox gene is essential for prostate gland 
development in utero and continued maintenance, but also appears to have tumour suppressor 
activity (Abate-Shen, Shen & Gelmann 2008; Zhang et al. 2007). A decrease in expression, without 
genetic alteration, was observed in PIA (Bethel et al. 2006). As this protein may also be involved in 
reducing oxidative stress, reduced expression may cause an increase in oxidative stress increasing 
cellular injury, including DNA damage. These effects are associated with carcinogenesis, so the early 
changes in gene expression in PIA may contribute to cancer development.   
Another precancerous state is PIN, which is characteristically more similar to prostate cancer than PIA, 
with abnormal malignant cell proliferation (neoplasia) and abnormal cellular features, however unlike 
cancer, the basement membrane (a layer separating epithelium from other tissue) has not been 
degraded in PIN (Packer & Maitland 2016). While it’s possible that PIA may transform to cancer, there 
is evidence that PIA may transition to high grade-PIN (HGPIN), a form of PIN more closely resembling 
cancer than any other precancerous lesion. In some PIA lesions there are atrophic epithelial cells which 
have developed abnormal characteristics more typical of cells within HGPIN lesions, and these 
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particular lesions likely represent a transition state between PIA and HGPIN (Wang, Bergh & Damber 
2009). Additionally, PIA and HGPIN have been observed to arise within the same location and 
frequently merge also suggesting a developmental relationship (Putzi & De Marzo 2000). There is a 
very strong association between HGPIN and PCa. Approximately 40% of patients with HGPIN develop 
cancer within three years and approximately 80% within eight years (Park et al. 2014). Investigation 
of the alterations occurring between HGPIN and PCa found that HGPIN exhibits genome changes 
associated with tumour development, however the transition to cancer would necessitate further 
genetic alterations. The carcinogenic process involves many genetic alterations, such as mutations or 
changes in copy number, which all contribute to cancer progression. Many of the genome alterations 
are likely to occur in the late stages of HGPIN or early stages of cancer (Jung et al. 2016). Changes in 
NKX3.1 expression is also affected in PIN, where there is reduced expression without chromosomal 
deletion in low grade-PIN, whereas reduced expression in HGPIN may be due to genomic deletion 
(Bethel et al. 2006). While a chromosomal deletion of NKX3.1 is observed in only some HGPIN lesions, 
the occurrence in PCa is significantly higher, with one study observing the deletion in all cancer 
samples (Jung et al. 2016).  
After a diagnosis of PCa, staging of the disease is important to determine appropriate treatment and 
the risk of death varies depending on the stage and grade. Stage is represented by the tumour, node 
and metastasis classification (TNM) and grade is classified by the Gleason grading system (Table 1).  
PSA levels can also be informative (as outlined in Table 2) and these levels are used to measure 
treatment effectiveness and evidence of reoccurrence (Paller & Antonarakis 2013). PCa biopsies and 
in some cases, lymph node (groin) biopsies are examined by a pathologist to determine the tumour 
(T) and the node (N) and various scanning modalities (such as ultrasound, X-ray, bone scans and 
computer tomography) are used to determine the metastasis (M). The clinical staging of primary 
tumours (T) begins with clinically apparent tumours in the T1 stage, progressing from T1a with 
histological evidence of the tumour in less than 5% of the tissue tested to T1c, with raised PSA and 
evidence of a tumour cells in the biopsy. T2 stage tumours are localised to the prostate, affect less 
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than one half of a lobe in T2a to affecting both lobes in T2c. Invasion beyond the connective tissue 
surrounding the prostate occurs in stage T3 cancer, on either one side or both sides of the prostate in 
T3a cancer, and invasion of the seminal vesicles in the T3b stage. The T4 stage involves invasion of 
tumour cells into adjacent tissue and organs including the urinary bladder, rectum or pelvic wall. 
Clinical staging of cells in lymph nodes defines NX and N0 as not assessed and no lymph node invasion 
respectively, and N1 as invasion of the cancer into regional lymph nodes in the groin. Metastases are 
classified as no metastasis into distant tissues or organs in M0 or metastasis occurring in M1. M1 is 
subclassified as M1a affecting lymph nodes other than regional nodes: M1b involves invasion of 
prostate cancer cells into the bone: and M1c as metastasis or presence or cancer cells in other tissues 
(Cheng et al. 2012).   
The Gleason grading system for PCa is based on histological examination of biopsies from the prostate, 
observing the characteristics of the tissue, illustrated in Figure 3 (Gleason & Mellinger 1974). The 
lowest pattern of 1 represents normal cells that are well differentiated and the highest pattern of 5 
represents cells that are anaplastic, which are poorly differentiated and display abnormal morphology.  
The Gleason score is calculated by adding two patterns observed together, therefore if Gleason 3 and 
Gleason 4 patterns are observed in a biopsy this forms a Gleason score of 7 (Gleason & Mellinger 
1974). The Gleason score is important in staging PCa as it is strongly associated with the aggressiveness 
of the cancer (Chen & Zhou 2016). PSA, also called human kallikrein 3 (hK3), is produced by prostate 
luminal cells and is used for PCa screening, based on the ratio of free PSA and bound PSA (bound to 
molecules in the serum). PSA levels are also useful in staging PCa (Bryant & Lilja 2014).   
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Figure 3: The Gleason pattern classification (Gleason Score  2017)  
  
Table 1: American Joint Cancer Commission (AJCC) stage grouping system (Clinical staging  2014)  
 
Treatment of PCa depends on the risk classification which is determined by the stage and grade of the 
tumour. Low risk patients have T1c to T2a tumours, low PSA, and biopsy Gleason score 6. The biopsy  
Gleason score is calculated based on histological appearance of the cells. Moderate PSA, Gleason score 
7 and cancer staging of T2b-c is considered intermediate risk cancer and high PSA, Gleason score 8 or 
higher and cancer staging of T3a or higher is high risk PCa (Heidenreich et al. 2014). Patients with low 
risk cancer may not receive treatment initially but be under active surveillance, as some cases of PCa 
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are indolent and will not pose a risk of death within the life expectancy of the patient, particularly in 
individuals over 70 years of age. In cases where the cancer is not indolent and therefore active 
surveillance is not appropriate, radical prostatectomy (surgical removal of the prostate) is a common 
treatment for localised PCa (Heidenreich et al. 2014). This treatment is associated with complications, 
as incontinence and impotence may occur after surgery, and may have a significant impact on quality 
of life even for patients in remission (Bianco, Scardino & Eastham 2005).   
Radiation therapy or low dose brachytherapy, where the radiation is provided by an implant inserted 
into the prostate can also be used. In intermediate and high-risk cases, radical prostatectomy and 
androgen deprivation therapy (ADT), which prevents androgen stimulated tumour growth, can be 
used in conjunction with radiation therapy in intermediate and high-risk cases (Heidenreich et al. 
2014). Side effects are also observed in radiation therapy with urogenital effects, including 
inflammatory obstruction of the urethra causing painful urination and increased urgency, sexual 
dysfunction, and gastrointestinal irritation causing increased urgency, bleeding and diarrhoea 
(Michaelson et al. 2008). These complications of therapy are important considerations for the quality 
of life of prostate cancer patients.   
While ADT is a mainstay treatment for high risk and invasive PCa, its use is associated with metabolic 
syndrome in patients (Rezaei et al. 2016). The defining features of metabolic syndrome are insulin 
resistance or Type II diabetes, obesity, dyslipidaemia (abnormal triglyceride and cholesterol levels), 
and hypertension, which are associated with cardiovascular disease (CVD) (Huang 2009). Metabolic 
syndrome has been observed to occur in over half of the patients being treated with long term ADT, 
compared with only one in five in those not treated with ADT. The main metabolic changes in patients 
with metabolic syndrome were high blood sugar levels and increased fat deposition in the abdominal 
region, which were not influenced by other factors such as age or race, therefore hypogonadism was 
proposed as the cause of metabolic syndrome in ADT treated patients (Braga-Basaria et al. 2006). 
Intermittent ADT is still associated with an increased risk of metabolic syndrome, however the risk is 
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significantly lower than that of long term therapy, further supporting the role of ADT in metabolic 
syndrome (Rezaei et al. 2016). As metabolic syndrome is associated with CVD, the development of this 
syndrome caused by ADT would further increase risk of death, due to both CVD and cancer related 
mortality.  
1.3 Genetic changes driving the development of prostate cancer  
  
In the prostate, normal function is reliant on androgen signalling via the AR, located intracellularly as 
shown in Figure 4. Without androgen signalling there is reversible regression of the epithelium, which 
recovers upon reintroduction of the hormones. The interactions between stromal and epithelial cells, 
and androgen signalling is complex and well regulated. AR activation in the supportive stromal cells 
results in the release of paracrine growth factors, called andromedins, which stimulate epithelial 
proliferation and differentiation, thereby forming the secretory luminal cells (Antony et al. 2014). This 
AR mediated response in epithelial cells results in terminal differentiation where the cell has reached 
maturation and will no longer undergo proliferation. Thus AR signalling in the epithelium supresses 
growth and does so via downregulating expression of a transcription factor, c-Myc.  
In PCa however, AR signalling in the epithelium induces growth of the tumour as the AR in tumour cells 
upregulates the expression of c-Myc (Vander Griend, Litvinov & Isaacs 2014). Stromal AR activation is 
necessary for carcinogenesis in the prostate as deletion of stromal AR prevented cancer development 
and advancement, while cancer progression still occurred with epithelial AR deletion (Ricke et al. 
2012). Changes in the AR signalling pathway have been observed to occur in over half of all primary 
tumours and all metastatic cancers, although mutations and increased copy numbers of the AR gene 
itself typically only occurs in advanced metastatic cancer. AR signalling induces proliferation via c-Myc, 
therefore changes downstream may be a mechanism involved in carcinogenesis (Taylor et al. 2010). 
c-Myc overexpression is common in many cancers, including breast, colon and PCa. There are often 
extra copies of c-Myc in advanced PCa, however in early stages this amplification rarely occurs. Despite 
this, c-Myc overexpression appears to be an important factor in carcinogenesis as c-Myc is involved in 
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many cancer cell processes, but in PCa its upregulation leads to proliferation but prevents terminal 
differentiation, promoting carcinogenesis (Hawksworth et al. 2010).  
 
Figure 4: Androgen receptor signalling in the prostate, typical and atypical activation (Lonergan & 
Tindall 2011)  
  
The transmembrane prostate androgen-induced protein precursor (PMEPA1) is produced in response 
to AR activated transcription. It functions as a regulatory protein, as it binds directly to the AR and 
initiates degradation of the AR protein, thereby creating a negative feedback loop (Li et al. 2008). 
Reduced expression of PMEPA1 has been observed in PCa, which has been associated with an 
increased AR function. Methylation (the addition of methyl groups to a gene promoter region) of the 
PMEPA1 gene, has been linked to gene silencing in PCa and is suggested to be an important step in AR 
driven cancer development (Li et al. 2015; Sharad et al. 2014). PMEPA1 silencing has also been linked 
to metastasis in mouse models and humans, and associated with reduced survival (Fournier et al.  
2015).  
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NF-κB is another transcription factor involved in PCa. It is usually inactive in the cytoplasm of normal 
epithelial cells and in the nuclear membrane of basal cells. Upregulation of cytoplasmic NF-κB was 
seen in precancerous PIN lesions suggesting a role in early carcinogenesis. Nuclear translocation and 
overexpression of NF-κB is observed in more advanced disease and is linked with a poorer outcome 
(Domingo-Domenech et al. 2005). NF-κB is also involved in inflammation where it promotes expression 
of inflammatory cytokines and recruitment of immune cells, and is also itself upregulated by other 
cytokines, including interleukin-1 (IL-1). The increased expression in PIN is likely associated with the 
inflammation occurring in the lesion and eventually as the cancer progresses, NF-κB becomes 
overexpressed (Nguyen et al. 2014).   
1.4 Impact of diet on prostate cancer development  
  
The reports of higher  rates of PCa in Western countries compared to developing countries, has been 
attributed to the high fat, high carbohydrate ‘Western Diet,’ which includes a high consumption of 
meats, both red and processed, and many other fatty, sugary foods (Fabiani et al. 2016). Although a 
portion of the higher risk in Western countries can be attributed to better screening, the lifestyle and 
diet appears to be a significant factor (Kimura 2012). Investigations into whether specific foods, such 
as red meats are associated with increased risk of PCa have not yielded strong evidence of a 
relationship in meta-analyses and pooled analyses (Bylsma & Alexander 2015; Wu et al. 2016) so it is 
likely that the Western diet as a whole may have a greater influence on PCa development and 
progression compared to individual food types. A meta-analysis performed by Fabiani et al. (2016) 
compared the trends occurring in healthy, Western, and carbohydrate dietary patterns. As expected, 
the healthy diet was not associated with PCa and had a small, but not significant, reduction in risk. The 
Western diet was associated with a significant increased risk of PCa from an analysis of 12 studies. 
Additionally, analysis of the dose response, found that the risk of PCa also increases as the intake of 
the diet adheres more to the Western type foods (Fabiani et al. 2016).   
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Deep-frying food is a cooking method common in the Western diet, which increases dietary fat 
content. Additionally, the high heat conditions while cooking alters the structure of the fats, 
transforming unsaturated fats to trans fatty acids and causes formation of carcinogens, such as 
aldehydes, hydrocarbons, and heterocyclic and polycyclic amines (Stott-Miller, Neuhouser & Stanford 
2013). Frequent intake of deep-fried foods was associated with an increased risk of PCa, while there 
was also a greater association with high risk PCa. The increased risk was attributed mainly to the 
regular consumption of high fat, high carbohydrate deep-fried fast food, while not finding a strong link 
between carcinogen formation and PCa risk (Stott-Miller, Neuhouser & Stanford 2013). High 
cholesterol is also a common feature of the Western diet and associated with metabolic disorder. A 
large prospective cohort study investigated the link between plasma cholesterol and PCa finding no 
increased occurrence of the disease, but did find a heightened risk of an aggressive form of PCa 
(Shafique et al. 2012). These results suggest that cholesterol may be more important in advanced 
progression of cancer, which would require a constant source of cholesterol for plasma membrane 
formation in aggressive cancer growth.  
There is also evidence that the Western diet, which results in increased fat deposition and cholesterol 
levels, promotes cancer progression in a mouse model of PCa. It was also found that a plasma 
membrane receptor which selectively takes up high density lipoprotein (HDL)-cholesteryl ester, 
scavenger receptor class B type I (SR-BI), is increased in the PCa cells which would support tumour 
growth as cholesterol is essential for forming the plasma membrane of cells (Llaverias et al. 2010). As 
the Western diet is high in cholesterol, the cancer would have a generous supply of cholesterol for the 
plasma membranes of proliferating tumour cells. Furthermore, there was an increase in blood vessel 
growth (angiogenesis) in the tumour, an essential feature in cancer growth and invasion, and also 
supplying the tumour with essential nutrients including cholesterol (Llaverias et al. 2010). The 
occurrence of metastasis to the lungs was also significantly higher in mice fed the Western diet, a likely 
outcome of increased blood vessel formation and cholesterol uptake (Llaverias et al. 2010). There is 
also evidence of the Western diet impacting survival rates in humans. In patients who consume a 
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Western diet after diagnosis with nonmetastatic cancer, there was an overall increased risk of death, 
whereas individuals who consumed a healthier diet after being diagnosed appeared to lower the 
overall risk of death (Yang et al. 2015).   
1.5 Diet and inflammation  
  
There is a strong association between obesity and inflammation, with macrophage infiltration into 
adipose tissue and proinflammatory cytokine release from adipose tissue occurring in obesity. Obesity 
is often associated with a hypercaloric, red meat-based, high fat and high carbohydrate diet, common 
features of the Western diet (Johnson & Makowski 2015). The excessive fat accumulation in 
adipocytes leads to activation of pathways promoting insulin resistance and inflammation. A high fat 
diet in mice has been shown to lead to activation of an inflammasome, a multiprotein complex, which 
causes downstream activation of many inflammatory cytokines and cleavage and deactivation of 
sirtuin 1 (SIRT1), the loss of which is associated with metabolic dysfunction (Chalkiadaki & Guarente 
2012). A rat study has also shown that elevated consumption of beef, a red meat, even for a short 
term resulted in an increase in inflammation and oxidative stress (Van Hecke et al. 2016).    
There is also a strong link between PCa and diabetes which further supports a role for diet and 
metabolism in PCa development. A meta-analysis of PCa patients found that pre-existing type 1 or 
type 2 diabetes were both associated with an increased risk of death, and type 2 diabetes doubled the 
risk (Lee, Giovannucci & Jeon 2016). The likelihood of advanced cancer is increased in patients with 
diabetes as high blood sugar levels promote tumour growth, and the effectiveness of radiation therapy 
may be reduced in patients with this condition (Lee, Giovannucci & Jeon 2016).   
1.6 Inflammation and prostate cancer   
  
Inflammation has been proposed as a contributing factor in various epithelial cancers including PCa. 
The presence of inflammation in prostate biopsies is associated with the development of PCa, and a 
greater level of inflammation is linked to high-risk PCa (Gurel et al. 2014). Inflammation has been 
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shown to induce oncogenic alterations in epithelial basal cells, leading to differentiation to luminal 
cells, the phenotype seen in adenocarcinoma. Basal cells possess the capability for differentiation to 
the luminal lineage, however in normal tissue this has rarely been observed. Genomic alterations are 
also more common in basal than luminal cells, and apoptosis occurs less frequently in basal cells. 
Inflammatory signalling is a likely trigger for the change in differentiation, and may also contribute to 
genetic and epigenetic changes, suggesting a role in inflammatory induced basal origin of 
adenocarcinoma (Kwon et al. 2014). Inflammation in the prostate is associated with subpopulations 
of luminal cells that have low expression of the luminal marker CD38. These cells display PIA like 
characteristics and also have increased expression of NF-κB, which is suggested to predispose the cells 
to tumorigenesis and development of aggressive cancer (Liu et al. 2016). While NF-κB overexpression 
is important in tumourigenesis as previously discussed, it is not linked to cancer development when 
occurring alone, however a synergistic effect has been observed with c-Myc overexpression (Jin et al.  
2014).   
Inflammatory signalling is important in the link between inflammation and tumorigenesis. Interleukin6 
(IL-6), is a proinflammatory cytokine released by immune cells, cells lining blood vessels and tumour 
cells. Increased IL-6 production in the prostate in an inflammatory setting is associated with immune 
cell infiltration in the prostatic tissue and surrounding adipose tissue. Continuous production of IL-6 in 
chronic inflammation initiates epigenetic changes which promotes tumourigenesis and can cause 
development of a neoplasm. Additionally, it can also induce autocrine (affecting the cell that produced 
the cytokine) IL-6 signalling, insulin-like growth factor (IGF) paracrine signalling, and further promotes 
inflammation (Liu et al. 2017). IGF upregulates cellular proliferation and enhances cell survival, and 
human studies have found that increased IGF levels in serum is linked to increased risk of PCa (Roddam 
et al. 2008; Weroha & Haluska 2012). Il-6 is also an alternative activator of the AR in PCa cells, as first 
reported by Hobisch et al. (1998). IL-6 activation of the AR promotes the growth of prostatic tumours 
and metastasis often occurs in organs in which IL-6 is produced. NF-κB can also induce IL-6 expression, 
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demonstrating the complex interaction of transcription factors and cytokines in inflammatory related 
tumourigenesis (Malinowska et al. 2009).   
Infiltration of immune cells also appears to be an important factor in PCa and inflammation. 
Macrophages have been observed promote a cancerous effect via tumour necrosis factor, as well as 
promote inflammation and progression of cancer in the prostate. The presence of tumour associated 
macrophages is associated with advanced cancer and poor outcomes, as well as recurrence of cancer  
(Nonomura et al. 2011). Macrophages are also involved in tumourigenesis, as shown by Fang et al. 
(2013) in a culture of macrophages and normal prostate epithelial cells. The culture was found to 
increase expression of various chemokines including C-C Motif Chemokine Ligand 4 (CCL4) and its 
receptors, which was found to inhibit expression of the tumour suppressor genes, tumour protein p53 
and phosphatase and tensin homolog (PTEN). This chemokine and its receptors are upregulated by 
macrophage AR expression, as indicated by an inhibition of this effect when the macrophage AR is 
silenced (Fang et al. 2013). Infiltration of macrophages and these epigenetic changes may be important 
in the development of the precancerous PIN lesions and subsequent tumourigenesis.   
1.7 Phytochemicals and cancer prevention  
  
An area of investigation is the prevention of PCa using various dietary phytochemicals, including 
lycopene, curcumin and resveratrol, though in some cases these studies have yielded mixed results. 
Lycopene is a carotenoid (fat-soluble coloured pigment) occurring in high concentrations in processed 
tomato products, such as tomato sauce. It is an effective antioxidant, as such has been investigated 
for its cancer preventative effects (Giovannucci et al. 2002). A prospective cohort study of over 50 000 
individuals examined the relation of dietary items to PCa and found a significantly decreased risk of 
PCa associated with lycopene intake, in men over 65 years of age (Giovannucci et al. 2002). A more 
recent follow up of the same individuals suggested that long-term intake of lycopene appeared to 
reduce the risk of lethal PCa, but was less important in reducing total cases (Zu et al. 2014). Other 
studies have found contradictory results, including a prospective study and a case controlled study, 
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both investigating the same population of nearly 30 000 men. These two studies found no association 
between lycopene intake and risk of PCa (Kirsh et al. 2006; Peters et al. 2007). Similar findings were 
also reported in a Prostate Cancer Prevention Trial involving around 10 000 men, where dietary 
nutrients including lycopene were found to have no impact on risk on PCa, including high-grade cancer 
(Kristal et al. 2010).  
The spice turmeric contains an active compound curcumin, another potent antioxidant with potential 
as an anticarcinogenic agent (Sandur et al. 2007). Human trials of curcumin in patients at high risk of 
colorectal and other types of cancers have observed an anticarcinogenic effect in some patients, 
including histological improvements of some precancerous lesions (Carroll et al. 2011; Cheng et al. 
2001). Curcumin also has many cancer and antitumourigenic effects on prostate cells, involving 
inflammatory pathways and alterations in expressions of genes related to carcinogenesis. Studies have 
shown that curcumin can antagonise the alternate activation of the AR by the inflammatory cytokine  
IL-6, and inhibit activation of NF-κB, both pathways observed in inflammation and PCa (Sandur et al. 
2007; Tsui et al. 2008). Curcumin has also been shown to downregulate the Hedgehog signalling 
pathway, which is vital for normal cell proliferation and differentiation but often becomes 
dysregulated and overexpressed in PCa (Ślusarz et al. 2010).   
Resveratrol is found in some fruits and red wine as a phytoalexin, a compound produced by plants in 
response to environmental stress, and has antioxidant, anti-inflammatory and antitumourigenic 
effects (Benitez et al. 2009). The prevention of cancer by resveratrol has been observed in a reduction 
of oesophageal tumour formation as well as inhibition of angiogenesis, a hallmark of cancer, in lung 
carcinoma tumours in rodent models (Kimura & Okuda 2001; Li et al. 2002). In PCa cells resveratrol 
has been shown to inhibit AR activation, which results in an upregulation of PTEN, with tumour 
suppressor activity, overall reducing PCa growth (Wang et al. 2010). It has also been shown to reduce 
activation of NF-κB (Benitez et al. 2009). A phase I trial in humans determined that resveratrol taken 
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orally was safe and produced biologically relevant plasma concentration, though the anticarcinogenic 
effects would have to be further investigated in humans (Boocock et al. 2007).   
1.8 Capsaicin   
  
Capsaicin is a phytochemical found in Capsicum species. It is a type of capsaicinoid (shown in Figure 
5), an amide produced in the fruit that causes the spicy, pungent sensation when eaten. Capsaicin is 
the main capsaicinoid occurring in chilli extract, comprising approximately 69% of the total content 
(Wahyuni et al. 2013).  Capsaicin activates the transient receptor potential vanilloid 1 (TRPV1), a 
receptor belonging to a family of nonselective cation channels, causing influx of calcium and sodium 
ions into the cell, and the sensation of heat and pain. TRPV1 is also activated by acidic conditions, high 
temperatures and some toxins (Yang & Zheng 2017). Capsaicin has been shown to have anti-cancer 
activity caused by binding and activation of TRPV1 in urothelial cancer cells via activation of 
proapoptotic proteins leading to cell death (Amantini et al. 2009). An important mechanism of 
apoptosis, as observed in microglial cells, is the influx of calcium caused by TRPV1 activation by 
capsaicin, which causes mitochondrial damage causing leakage of cytochrome c, a molecule which 
forms an apoptotic complex and irreversibly initiates apoptosis (Kim et al. 2006). Human prostate 
tissue expresses TRPV1, including the epithelial cells confirmed by increases in intracellular calcium 
concentrations in response to capsaicin, and expression of TRPV1 increases in PCa (Czifra et al. 2009; 
Sánchez et al. 2005). It is important to note that capsaicin activation of TRPV1 is followed by 
desensitisation of the receptor, during which it can no longer be activated for a period of time, 
depending on the dose and location. Prolonged capsaicin activation has been observed to lead to 
removal of the receptor from the plasma membrane, causing long term desensitisation (Sanz-Salvador 
et al. 2012).   
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Figure 5: Phytochemicals in Capsicum species (Wahyuni et al. 2013)  
  
Evidence also suggests that the mechanisms of capsaicin’s cancer activity is partially TRPV1 
independent, as the use of a TRPV1 antagonist was unable to prevent apoptosis in PCa cells in response 
to capsaicin treatment. Capsaicin inhibits pathways important in generating antioxidants and 
increases reactive oxygen species (ROS) production, thereby increasing oxidative stress. There is an 
initial peak of ROS production, occurring within 15 minutes of the addition of capsaicin to PCa cells, 
and a later peak of ROS production at 10 hours associated with disruption of the mitochondrial 
membrane. In mice grafted with human PCa cells both capsaicin and capsazepine, a TRPV1 antagonist, 
caused apoptosis at similar rates, indicating a TRPV1 independent mechanism of cell death (Sánchez 
et al. 2006).  
Another receptor in the TRPV family TRPV6, a highly selective calcium ion channel, like TRPV1 is 
present in many tissues and has also been linked to capsaicin cancer activity in some cancer types. In 
gastric cancer the calcium influx and resulting induction of apoptosis is due to TRPV6 activation and is 
prevented by silencing of TRPV6 expression with RNA interference, whereas inhibiting TRPV1 had no 
effect (Chow et al. 2007). Capsaicin has also been observed to cause apoptosis via TRPV6 activation in 
small cell lung cancer by calcium influx but also by the calcium dependent calpain pathway, a group of 
enzymes which degrade proteins and are important in regulation of cell differentiation and apoptosis 
(Lau et al. 2014). TRPV6 is also highly expressed in PCa and increasing expression is associated with 
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high risk cancer. A moderate increase in calcium uptake by TRPV6 may promote cell growth and 
survival in cancer, whereas a continuous increase in calcium uptake, such as what occurs when 
capsaicin activates the receptor, causes mitochondrial membrane injury and promotes apoptosis 
(Lehen'Kyi et al. 2007).   
There are various proteins and pathways which exhibit changes in expression in precancerous states 
and mutations or copy number alterations in PCa, and capsaicin has been observed to affect many of 
the targets. In androgen sensitive cells, low concentrations of capsaicin (0.01 to 20 µM) have been 
shown to increase cell proliferation via an increase in AR expression which was dependent on TRPV1 
activation, however at higher concentrations of capsaicin (50 to 100 µM) an antiproliferative effect 
was observed (Malagarie-Cazenave et al. 2009; Zheng et al. 2015). At higher concentrations (100 μM), 
capsaicin caused overexpression of a small non-coding microRNA which caused an inhibition of 
expression and degradation of the AR, preventing cell growth in the AR dependent cells (Zheng et al. 
2015). In androgen independent cells, capsaicin caused an increase in TNF and IL-6 concentration 
which was associated with inducing cell death (Malagarie-Cazenave et al. 2011). Considering the dose 
dependent desensitisation of capsaicin on TRPV1, the higher doses may also be preventing TRPV1 
activity after the initial activation.   
Although capsaicin has been shown to promote inflammatory cytokine production in cancer cells, it 
appears to have an anti-inflammatory effect on macrophages, representing a possible anti-
inflammatory effect on tissues with macrophage infiltrations. Capsaicin was observed to both prevent 
production of TNF and cause inactivation of NF-κB in macrophages (Kim et al. 2003; Park et al. 2004). 
A more recent study showed that capsaicin had an inhibitory effect on induced inflammation in mice, 
corresponding with lower concentrations of markers of inflammation, however the infiltration of 
immune cells remained normal, suggesting the protective immune response against infections is not 
affected by capsaicin but excessive inflammation is downregulated (Jolayemi & Ojewole 2013).  
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Capsaicin has previously been shown to prevent NF-κB expression and the expression of another 
oncogene, complex activator protein 1 (AP-1), in mouse skin (Surh et al. 2000). The mechanisms 
involve protection of IκB-α, a protein which is normally bound to and therefore inhibits degradation 
of NF-κB, and prevents binding of AP-1 to DNA, inhibiting its oncogenic effect. The inhibition of activity 
of both NF-κB and AP-1 by capsaicin suggests an antitumourigenic effect (Han et al. 2001). Capsaicin 
has also been shown to be beneficial in obesity associated inflammation, by normalising cytokine 
release form adipocytes which are dysregulated in obesity. Adipokines, including IL-6, are cytokines 
released from adipocytes causing obesity associated inflammation and the addition of capsaicin to the 
diet of obese mice reduced inflammatory adipokine release, decreased macrophage infiltration in the 
adipose tissue and increased the release of the anti-inflammatory hormone, adiponectin (Kang et al. 
2007).   
A mouse model has investigated the anticarcinogenic properties of capsaicin in the transgenic 
adenocarcinoma of the mouse prostate (TRAMP) model, where prostate adenocarcinoma is induced 
by a mutation (probasin- SV40 T-antigen). The long-term administration of capsaicin (5 mg/kg body 
weight) resulted in reduced progression to metastatic cancer, with no indications of toxicity (Venier et 
al. 2015).  
Knowledge gaps and future directions   
  
The current evidence suggests that a high fat and high carbohydrate diet (Western diet) can induce 
inflammation in many tissues and organs in the body, including the prostate gland. Additionally, 
inflammation can promote carcinogenesis and cancer progression via several mechanisms. Capsaicin 
has been shown to reduce inflammation in multiple tissues and organs, therefore can it reduce 
inflammation in the prostate and prevent inflammation induced carcinogenesis in the prostate? 
Currently there has not been research published into whether capsaicin can prevent changes in the 
expression of inflammation and PCa associated genes and protein levels that are caused by a high fat 
and high carbohydrate diet in the prostate gland. As the incidence of prostate cancer increases 
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worldwide, less expensive and lower toxicity approaches for treatment and prevention are urgently 
required. Supplementing the diet with an inexpensive and readily available phytochemical such as 
capsaicin may provide a solution.     
In developed countries, the consumption of a high fat, high carbohydrate Western diet is associated 
with inflammation in the prostate gland. Precancerous lesions, PIA and PIN, develop in association 
with inflammation, and display changes in expression of various genetic pathways which eventually 
lead to the tumourigenesis of PCa. Previous research has shown anti-inflammatory properties of 
capsaicin in numerous tissues in the human body, therefore this study has investigated whether the 
addition of capsaicin to a high fat, high carbohydrate diet in male Wistar rats could prevent or reverse 
the inflammation associated with the diet and also investigated if capsaicin could prevent or reverse 
the alterations in gene expression associated with the early development of PCa.  
  
     
29  
  
Project hypothesis:  
  
The hypothesis of this study is that the addition of capsaicin to a high fat and high carbohydrate diet 
would prevent or reverse the gene and protein expression changes that drive diet-stimulated PCa 
tumourigenesis.   
Project aims:  
  
Using a male Wistar rat model of diet-induced obesity:   
1. Measure the relative expression of genes in the prostate gland of rats fed either a balanced, 
control diet (CS), a diet representative of the Western diet (high in fat from mammalian sources 
and high in fructose, HCHF), a CS diet supplemented with (0.015%) capsaicin or the HCHF diet 
supplemented with (0.015%) capsaicin. This includes genes in the androgen receptor pathway, 
NF-κB cell signalling pathway and TRPV pathway. 
2. Determine the effects of the HCHF diet and capsaicin supplementation on protein levels of the 
proliferation marker MEK1 in the prostate gland. 
3. Determine the histological changes, specifically the presence of inflammatory cells in the  
 prostate gland in response to the HCHF diet.   
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Chapter 2: Materials and Methods  
  
2.1 Animal Protocol  
  
The animal protocol was completed by Edward Bliss and the Functional Foods Group at the University 
of Southern Queensland, Toowoomba campus. Briefly, male Wistar rats (eight to nine weeks old; 338 
± 7 g) were acclimatised for three weeks before being randomly divided into four experimental diet 
groups. The diets consisted of either a corn starch-based (CS) diet or high-carbohydrate high-fat 
(Western Diet, HF) diet for 16 weeks, or a corn starch-based diet for eight weeks with the addition of 
0.015% capsaicin for the following 8 weeks (CC) or a high-carbohydrate high-fat diet for eight weeks 
with the addition of 0.015% capsaicin for the following 8 weeks (HC).    
At the end of the protocol, rats were euthanised and prostate samples dissected for quantitative 
RTPCR were stored in RNA Later (QIAGEN) and samples for Western Blotting were stored in RIPA buffer 
(25mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, Protease inhibitors) 
at -80°C.  
2.2 RNA extraction  
  
Prostate samples were homogenised using GentleMacs Dissociator (Miltenyi Biotec) and Qiashredder 
columns (QIAGEN). Total RNA from 30 mg of tissue was then extracted using RNAeasy Mini Kit 
(QIAGEN).   
2.3 Quantitative reverse transcriptase polymerase chain reaction (RT-qPCR)  
  
Total RNA was quantified and RNA integrity determined using the 2100 Bioanalyzer (Agilent) and 
equivalent amounts (100 nanograms) converted to complementary DNA (cDNA) with iScriptTM Reverse 
Transcription Supermix (Bio Rad). One microlitre of cDNA was amplified using Bio Rad CFX 384 real 
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time instrument, with SsoAdvanced™ Universal SYBR® Green Supermix using UBC or HPRT1 as a 
reference gene.   
Table 2: Primers used for Real Time Quantitative RT-PCR Analyses  
Primer Target  Unique Assay ID  Chromosome Location  
UBC  qRnoCED0057022  12:38519875-38519992  
HPRT1  qRnoCED0057020  X:153250276-153250384  
Androgen Receptor  qRnoCID0006751  X:68693047-68699818  
PMEPA1  qRnoCED0005395  3:177360138-177360237  
TRPV1  qRnoCID0003147  10:59545607-59548162  
TRPV6  qRnoCID0011754  4:135712922-135721028  
IL-6  qRnoCID0053166  4:3095863-3097287  
NF-kB1  qRnoCID0003698  2:259350292-259351746  
NF-kB2  qRnoCED0007287  1:273490070-273490162  
Myc  qRnoCID0007760  7:103160322-103161438  
NKX3.1  qRnoCED0001679  15:54797829-54797927  
Ki-67  qRnoCID0001488  1:214941606-214943149  
  
2.4 Western Blotting  
  
Samples stored in RIPA buffer were homogenised using liquid nitrogen and sonication and left for two 
hours before being centrifuged for 20 minutes at 12 000 rpm at room temperature. The supernatant 
was aliquoted to storage tubes. Protein lysates were quantified using BCA protein assay (Thermo  
Fisher).    
Equal quantities of protein lysates (20µg) were separated using SDS-PAGE (Bio Rad) at 110 mV for 
approximately one hour, then proteins were transferred onto PVDF membranes (Bio Rad Trans-Blot®  
Turbo™ Transfer System). The PVDF membranes were blocked in 0.1% Tween 20 Tris Buffered Saline  
(TBST) with 5% skim milk powder (Woolworths) on a plate shaker for one hour at room temperature.   
Using reagents from the Pierce™ Fast Western Blot Kit (Thermo Fisher), the membranes were washed 
in wash buffer (Thermo Fisher) before being incubated in the primary antibody, GAPDH (1:1000) or 
MEK1 (1:1000) (both Precision Antibodies from Bio Rad) at room temperature for 30 minutes on a 
plate shaker. The membranes were then incubated in Optimised HRP Reagent Working solution  
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(secondary antibody) (Thermo Fisher) for five minutes at room temperature. Chemiluminescence was 
detected using SuperSignal West Dura Working Solution (Thermo Fisher) and viewed using Fusion Fx 
(Vilber).   
2.5 Immunohistochemistry   
  
Rat prostate tissue samples were fixed in 10% formalin for four weeks and embedded in paraffin wax. 
Samples were cut into 5 µm sections and adhered to a slide. Sections were deparaffinised in two xylene 
washes, sequentially decreased concentrations of ethanol and 50mM Tris-HCL wash buffer. For heat 
induced antigen retrieval, slides were heated in a decloaking chamber in either Tri sodium citrate 
buffer or Tris-EDTA buffer for five minutes at 95°C then washed twice in 50mM Tris-HCL. Delineated 
sections were incubated in 3% hydrogen peroxide for five minutes then washed three times with 
50mM Tris-HCL. Biocare Medical Background SNIPER was pipetted onto sections for 10 minutes at 
room temperature to block before adding the primary antibody (against the macrophage and 
monocyte cell marker CD68, Precision Antibodies, Bio-Rad) diluted to 1:100 and 1:200 in Dako 
antibody diluent and IgG control for one hour. Slides were then washed three times in 50 mM TrisHCL 
then incubated with the secondary antibody (DAKO Envision+ Dual Link System) for 45 minutes. 1:50 
DAB solution (DAKO) was incubated on slides and washed in distilled water when colour developed 
then washed once in 50mM Tris-HCL. Slides were counter stained with Mayer’s Haematoxylin for two 
minutes, rinsed in distilled water and 0.1% ammonium hydroxide added for approximately 30 seconds 
before being rinsed off with distilled water. Slides were then dehydrated with sequentially increasing 
concentrations of ethanol and then two xylene washes before mounting with a coverslip (Eukitt quick 
hardening mounting media). Photographs of the slides were taken on an Olympus BX41 microscope 
with a microscope-mounted Nikon Coolpix 4500 digital camera (MicroPublisher 3.3 RTV, Olympus, Q-
Imaging).   
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2.6 Statistical analysis  
  
All data presented as mean +/- standard error of mean. Statistical significance (p > 0.05) as determined 
using one way ANOVA with Tukey’s correction. Analysis was performed in GraphPad Prism.  
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Chapter 3: Results  
  
3.1 Physiological Parameters:  
  
After the 16 weeks of protocol, the rats in the HF group had gained a statistically significant amount 
of weight in comparison to the control CS group. There was also a significantly greater weight gain in 
the HC group compared to the CC group. Most notably, the weight gain of the HF group was 
significantly higher in the HF rats compared to the capsaicin treated HC rats. These changes are 
illustrated in figure 6.  
Figure 6: Change in body weight 
 
 
Figure 6: Change in body weight 
calculated at end of 16 weeks 
experimental period. CS (n=3), HF CC and 
HC (n=5).   
Different lettering denotes statistically 
significant difference  
One way ANOVA with Tukey’s Post hoc 
(p= < 0.0001)  
  
  
3.2 Gene expression in prostatic tissue  
  
TRPV1 was excluded from the study as the expression in the prostate was too low to be reliable. Il-6 
was also excluded from the study due to unreliable results.   
Figure 7a illustrates the change in expression of TRPV6 compared to the CS group (as control CS = 1 or 
-1). There was a statistically significant increase in the HF group as shown in figure 7b. This effect was 
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not observed in the HC group, receiving the same diet with the addition of capsaicin for the last 8 
weeks of protocol. The small increases observed in the CC and HC group weren’t significantly higher 
than the control.  
Figure 7a: TRPV6 expression 
 
Figure 7b: Mean TRPV6 expression 
 
Figure 7a: TRPV6 expression  
Fold change compared to CS (1 or -1) n=3 
(HF2,CC4,CC5), n=2 (HF4,HC2,CC2)   
n=1 (HF5,HC1,HC3,HC4)  
Figure 7b: Mean TRPV6 expression  
Fold change compared to CS (1 or -1), n=3  
Different lettering denotes statistically significant 
difference (p= 0.0038)  
  
  
The prostate specific gene NKX3.1 demonstrated an increase in expression in three of four HF and CC 
animals (figure 8a), with larger increases observed in the CC group. Conversely three of four animals 
in the HC group showed a decrease in expression. There is a general trend towards an increase in 
NKX3.1 expression in the CC group (figure 8b), however the mean response of the HF and HC group 
is no different to the CS control (as control CS = 1 or -1).  
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Figure 8a: NKX3.1 expression 
 
Figure 8b: Mean NKX3.1 expression 
 
Figure 8a: NKX3.1 expression n=2 
(HF2-3,HF4,HC3-4,CC3,CC5)  n=1 
(HF5,HC2,CC2,CC4)  
Figure 8b: Mean NKX3.1 expression n=2  
  
  
  
Figure 9a shows the relative change of expression of the AR in the HF, CC and HC animals. There is a 
high degree of biological variation between the individuals ranging from a two-fold increase to a 
twofold decrease in HF, and from no change compared to CS (as control CS = 1 or -1) to 
approximately a three-fold decrease in HC and CC. The mean fold change (figure 9b) shows a small 
decrease in the HF and HC group compared to the CS group and the CC group showed no overall 
change compared to CS in response to either the diet or capsaicin.   
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Figure 9a: AR expression 
 
Figure 9b: Mean AR expression 
 
Figure 9a: AR expression n=2 
(HF2-4,HC1-2,HC5,CC3-5)  
n=1(HF5-6,HC3-4,CC1-2)  
Figure 9b: Mean AR expression n=2  
  
In figure 10a PMEPA1 showed only a slight increase in all animals compared to the CS group. Due to 
variation between the individual animals no overall trend is discernible. The greatest variation was 
seen in the HC group with very little change in HC3, and a two-fold change in HC4. As shown in figure 
10d the mean expression change demonstrates no difference between the groups, suggesting there is 
no effect of either the diet or capsaicin.  
The expression of the c-Myc (figure 10b) demonstrated a decrease in all individuals in the HF and HC 
group. There was no significant difference between the mean expression of the groups (figure 10d).   
In figure 10c the expression of the cellular proliferative marker Ki-67 demonstrates substantial 
biological diversity. In all groups there are both increases and decreases in expression however the 
mean expression change (figure 10d) shows no significant change in expression compared to CS (as 
control CS = 1 or -1).   
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Figure 10a: PMEPA1 expression 
 
Figure 10b: c-Myc expression 
 
Figure 10c: Ki-67 expression 
 
Figure 10a: PMEPA1 expression 
n=1 (all)  
Figure 10b: c-Myc expression n=1 
(all)  
Figure 10c: Ki-67 
expression n=3 (HF2-5,HC3-
4,CC2) n=2 (HC5,CC3-4)  
n=1 (HF6,HC1-2,CC1,CC5)  
Figure 10d: Mean expression of Ki-67, PMEPA1 &  c-
Myc  
n=1 (PMEPA1 & c-Myc), n=3 (Ki-67)  
Figure 10d: Mean expression 
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The expression of NF-kB1 in figure 11a shows no observable trends, with large variations between 
individuals of the same group and little change compared to CS (as control CS = 1 or -1), also shown by 
the mean expression (figure 11c).  
In figure 11b, the expression of Nf-kB2 in the CC group showed a consistent decrease in all individuals. 
Both HF and HC group showed greater variation with an increase in two individuals and a decrease in 
three individuals. The decrease in expression in the HC group animals is slightly greater than in the HF 
group as shown in figure 11c.  
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3.3 Prostate Histology  
  
Immunohistochemistry was performed on sections of rat prostate using CD68 (figure 12), a cell marker 
of inflammation by macrophages and monocytes (Bio Rad), however the protocol required further 
optimisation. The staining of CD68 cells could not be determined however the differences in histology 
of the prostate gland in the CS and HF rats demonstrated morphological differences with a slight 
increase in height of the epithelial luminal cells in the HF prostate compared to the CS and reduced 
glandular infolding in the HF prostate suggesting some cellular irregularities.  
 
  
Figure 12: Effect of diet on the prostate gland A: Control CS rat (100X), B: Western diet HF rat (100X)  
  
 
 
 
 
 
A   B   
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3.4 Western Blot  
  
In the Western blot (figure 13) the reference GAPDH showed diffuse banding, while no new bands 
were observed after incubation with MEK1, consequently the protocol requires further optimisation 
to provide results.   
  
CS1     CS2     CS3       HF2    HF3    HF4    HF5      HC1   HC2    HC3   HC4   HC5   CC1   CC2   CC3   CC4   CC5  
Figure 13: Western blot of protein samples with target GAPDH (reference) and Mek1  
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Chapter 4: Discussion  
  
The main findings of the investigation were the significant increase in TRPV6 gene expression in the 
prostate of rats fed a Western diet high in refined carbohydrates, and saturated fats compared to rats 
fed a normal diet and that the addition of capsaicin to this Western diet resulted in a statistically 
significant decrease in the gene expression of TRPV6. As TRPV6 is involved in prostate cancer 
tumourigenesis, the gene expression changes provide preliminary evidence that the addition of 
capsaicin to the Western diet can prevent diet-induced tumourigenesis in the prostate gland.   
TRPV6, previously known as calcium transport protein or calcium transport protein-like, is not typically 
expressed, or expressed at low levels, in normal prostatic tissue, whereas overexpression is observed 
in cancerous prostate cells (Wissenbach et al. 2001). Overexpression of TRPV6 has also been shown to 
increase cell survival in both cancerous and non-cancerous prostate cell lines via apoptotic resistance 
and promoting cell proliferation (Raphaël et al. 2014). TRPV6 over expression is also observed in 
cancerous prostate cells and is associated with high Gleason scores (Peng et al. 2001). The reduced 
expression of TRPV6 in the capsaicin treated rat receiving the Western diet rats compared to the rats 
receiving only the Western diet suggest there may be a preventative effect, considering the association 
of increased TRPV6 expression with prostate cancer.  
The increased expression of TRPV6 observed in this study suggests that the Western diet may be 
contributing to increased cellular proliferation via this receptor. As no significant effects were 
observed in other tumourigenic or proliferative markers, c-Myc, Ki-67, NF-kB1 and NF-kB2, the 
modification in expression of TRPV6 may be one of the earliest molecular changes in the rat prostate 
in response to a Western diet. Previously, the effect of diet on TRPV6 expression has only been 
reported in the intestine of rats, where a normal diet with 10% of calories from fat was compared to 
a high fat diet (45% of calories from fat) predominantly containing either monounsaturated fatty acids 
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or saturated fatty acids. No significant changes were observed in the intestinal expression of TRPV6 in 
response to diet (Wang et al. 2016). This study appears to be the first to examine TRPV6 expression in 
response to diet in the prostate and it would appear that unlike intestinal expression, TRPV6 
expression increases in response to a Western, high-carbohydrate, high-fat diet.   
When the rats were fed the Western diet supplemented with capsaicin for the last eight weeks of the 
protocol, the increase in TRPV6 expression stimulated by the Western diet was prevented. This may 
be due to capsaicin having an apoptotic effect on the proliferation-stimulated prostate cells.  
In lung cancer cell lines, capsaicin has been shown to induce apoptosis via TRPV6 whereas very little 
apoptotic activity was observed in normal lung cell lines. Additionally, it was also observed that lung 
cancer cell lines highly expressed TRPV6 and normal cells demonstrated considerably lower expression 
(Lau et al. 2014), similarly to the finding in prostate cancer (Raphaël et al. 2014). In gastric cancer cells, 
capsaicin causes apoptosis primarily via TRPV6, as silencing of the gene significantly reduces the 
apoptotic effect (Chow et al. 2007).   
Recently, a Phase I human trial in advanced solid cancers has been performed investigating the 
compound SOR-C13, a selective antagonist of TRPV6, with a high affinity for the receptor (Fu et al. 
2017). The compound was originally isolated from a peptide located in the salivary glands of the 
northern short-tailed shrew and shown to inhibit proliferation in 12 cancer cell lines by preventing 
TRPV6 calcium uptake, resulting in apoptosis. In some cell lines COR-C13 was as effective as the 
chemotherapy drug cisplatin, resulting in the progression of research to the phase I trial (Bowen et al. 
2013).  In the trial, 22 patients with various types of advanced solid tumours received at least one cycle 
(20 patients completed at least two) of SOR-C13 treatment. The safety profile was acceptable, with 
the main adverse reactions consisting of hypocalcaemia and hypersensitivity, treatable with calcium 
and vitamin D supplementation and antihistamines, and could be combined with other chemotherapy 
agents with a minimal risk of cumulative toxicity. After two cycles of SOR-13, half of the patients were 
observed to have stable disease, including in two out of the three patients receiving the lowest dose. 
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Based on the promising results of the trial, further research was recommended (Fu et al. 2017).  Given 
the anti-tumour effect in the trial, targeting TRPV6 shows excellent potential. In this study, the reduced 
expression of TRPV6 in the capsaicin treated HC rats suggests a possible chemopreventive mechanism 
of action for capsaicin.  
The effect of diet and capsaicin on NKX3.1 expression haven’t been previously studied. In a mutant 
mouse model of NKX3.1 with loss of both alleles of NKX3.1, dysregulation of genes coding for 
prooxidant and antioxidant enzymes were observed. This dysregulation could be seen as early as four 
months of age, eventually culminating in DNA damage, and the onset of pre-cancerous PIN lesions in 
mice over 12 months of age (Ouyang et al. 2005). The increased expression in the control corn-starch 
diet with the addition of capsaicin for most individuals would therefore suggest a potential beneficial 
effect. The increased expression of TRPV6 in the rats fed a Western diet and decreased expression in 
the rat fed the Western diet with the addition of capsaicin suggests the rats fed the Western diet 
would be more predisposed to forming pre-cancerous lesion with age, whereas the reduced TRPV6 
expression in the rats fed the Western diet and treated with capsaicin suggested a lower risk.   
In other tumourigenic or inflammatory genes, no statistically significant effects on expression were 
observed, with large biological variation occurring between individual animals of the same group.   
The AR signalling pathway is complex, with the effects of expression on the prostate dependent on 
downstream targets, such as c-Myc (Vander Griend, Litvinov & Isaacs 2014). In the context of high-fat 
diet induced obesity, the expression of the AR has been shown to decrease along with circulating 
concentrations of testosterone in the prostate of rats. The prostates of obese rats also showed fat 
accumulation, increased proliferation in the epithelial and stromal tissue and higher rates of 
precancerous PIN lesions. The increased proliferation induced by the high-fat diet was attributed to 
an increase in oestrogen receptor signalling and insulin resistance (Ribeiro et al. 2012). The effects of 
the hormone oestrogen and its receptors haven’t been explored in this study, but in future studies 
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would be important in elucidating the hormonal signalling effects of a Western diet on prostate 
tumourigenesis.   
PMEPA1 expression is induced by the AR, then forming a negative feedback loop inhibiting expression 
of AR downstream targets and inhibiting its activity, as shown by Xu et al. (2003). In prostate cancer, 
PMEPA1 is silenced by methylation and also exhibits down-regulation (Akinsete et al. 2011). There was 
no significant change in expression of PMEPA in this study, however methylation of gene was not 
studied and potentially changes may not be observed in the prostate until later stages of 
tumourigenesis.   
There was no significant change in c-Myc expression which is not entirely unexpected even though the 
AR promotes prostate cancer cell survival through c-Myc upregulation (Gao et al. 2013). In normal cells 
the highly regulated androgen dependent AR signalling causes a decrease in c-Myc expression, 
supressing growth and an upregulation of c-Myc is observe early in tumorigenesis, as demonstrated 
by Vander Griend, Litvinov and Isaacs (2014). Tumourigenesis is not expected to have occurred in the 
rats used in this study at their age (approximately 28 weeks), therefore no significant change in c-Myc 
expression is consistent with the literature of non-cancerous prostate cells.   
It would be expected that the expression of Ki-67 would increase in the Western diet fed rats, as 
previous research shows a high fat diet promotes proliferation of the prostate and therefore increases 
the expression of the proliferative marker Ki-67 (Kwon et al. 2016). The large decrease in some animals 
in the rats fed the high-carbohydrate, high-fat diet are unlikely to represent true results as the prostate 
in the HF were visually determined to be larger in size, therefore potentially errors in RT-qPCR 
procedure may account for this result, such as evaporation during plate loading or variation in cDNA 
conversion.   
The high level of variation observed in animals in regards to Nf-kB1 expression also prevents the 
observation of any trends. NF-kB1 encodes the p50 subunit which is involved in the classical signalling 
pathway of NF-kB. The alternate NF-kB pathway includes p52, produced from the NF-kB2 precursor 
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protein (Jin et al. 2015).  The expression of NF-kB2 in the CC group is consistently decreasing in all 
individuals, suggesting capsaicin may reduce the expression compared to the CS group. It is difficult to 
determine the response in the HF and HC group due to the variation between the animals. It was 
expected that NF-kB signalling would increase in the HF group, as previous research has shown 
increased activation of the NF-kB p65 unit in response to a high fat diet (Shankar et al. 2012).   
Histomorphological changes in rats fed a Western diet high in mammalian fat and simple 
carbohydrates suggested a negative impact on the prostate gland. A reduction in the presence of 
glandular infolding has been observed in a study of mice engineered to lack the expression of the 
epithelial AR. The mice developed various abnormal morphological features, including  
dedifferentiation, increased epithelial proliferation and sloughing off of epithelial luminal cells into the 
lumen of the gland, related to the loss of epithelial AR expression (Wu et al. 2007). This study has 
observed a minor decrease in AR expression in the Western diet fed rats where loss of glandular 
infolding was also observed. It is not known, however whether the expression of the AR could have 
been reduced differently in epithelial or stromal cells, and may be an interesting area for future 
research. Another study compared the morphology of the prostate gland in rats fed a control diet or 
various forms of high-fat diet, high in either saturated fatty acids, polyunsaturated fatty acids, or both. 
After approximately 16 weeks, the rats fed the high fat diets displayed abnormal cellular features, with 
the diet high in both saturated and unsaturated fatty acids showing the most significant increases in 
epithelial cell height, area density of stromal tissue and epithelial proliferation. The increase in 
epithelial cell height was attributed to a possible increase in the size of organelles, including the 
endoplasmic reticulum and the Golgi apparatus, therefore increasing their secretory abilities (Furriel 
et al. 2014). It would be beneficial to measure the PSA production in the prostate and serum 
concentrations to confirm if the changes in epithelial size correlate with PSA secretion.   
There were several limitations to this study. Predominantly, the small number of animals (three for CS 
and five for the other three groups) made determining statistical significance difficult due to the 
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variation between the animals. Using a larger number of animals will likely improve the ability to 
determine trends and statistical significance. Another difficulty was the sampling of the prostate, as 
determining the boundary of the organ was problematic, particularly with a large peri-prostatic 
adipose tissue layer, as observed in the rats fed the Western diet. As rats have multi-lobed prostates, 
a representative sample may not have been obtained for all animals, which may have interfered with 
expression of gene and account for some variation. Additionally, the integrity of RNA extracted for 
RTqPCR analysis can affect the results, and therefore stringent conditions during tissue collection and 
RNA extraction were required. The integrity of the RNA was determined using the Agilent Bioanalyser 
however, and all samples were suitable for further analysis. Variation in technical replicates was most 
likely due to variations in cDNA conversion prior to RT-qPCR. Due to limited availability of iScript 
required for the conversion, multiple batches of cDNA were produced, whereas the ideal situation for 
reproducible results would be to use one batch of stock cDNA for all for RT-qPCR replicates.   
From the results of this study, TRPV6 appears to be a promising target for capsaicin chemoprevention 
of prostate cancer. Supporting this is a case study of a prostate cancer patient who after receiving 
radiotherapy had an increase in PSA, indicating a biochemical failure, and due to side effects couldn’t 
tolerate other forms of treatment including ADT. The patient began taking capsaicin, in habaneros chili 
sauce, and during this time the PSA concentrations stabilised and resumed increasing after cessation 
of capsaicin ingestion (Jankovic, Loblaw & Nam 2010). 
 It would be beneficial to thoroughly investigate the effect of TRPV6 overexpression and inhibition in 
cell culture on the expression of genes related to proliferation and tumorigenesis. Additionally, the 
apoptotic signalling pathways should be studied as TRPV6 has been shown to induce apoptosis in 
cancer cell lines and these pathways could potentially be involved in the preventative effect (Chow et 
al. 2007).  
Furthermore, the use of older rats, particularly Lobund Wistar with the higher rate of testosterone 
induced prostate cancer, in a study could provide more clinically relevant information on the effects 
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of capsaicin on pre-cancerous prostate. This could determine if capsaicin may be used as a dietary 
intervention in men with pre-cancerous lesions to reduce the risk of progression to cancer.    
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Chapter 5: Conclusion  
  
This study investigated the effect of a high-carbohydrate, high-fat Western diet on gene expression 
and cell morphology in the prostate. Using RT-qPCR, it was shown that the expression of TRPV6, a 
capsaicin receptor which is also overexpressed in prostate cancer, was significantly increased in 
response to the Western diet. Notably, the increase in expression was not observed in rats receiving 
the same diet when capsaicin was included in the diet, suggesting a potential chemopreventive effect. 
The expression of other genes related to proliferation, tumorigenesis and inflammation showed no 
significant change. The morphology of the tissue in the prostate gland showed the occurrence of a 
number of abnormal changes in the Western diet fed rats compared to the control diet. The increased 
epithelial cell height and reduction of glandular infolding are associated with pre-cancerous changes 
in the prostate, suggesting the Western diet is inducing abnormal cellular alterations.   
As it appears capsaicin may have a chemopreventive effect in Western diet induced abnormalities in 
the prostate, future research should further investigate the tumourigenic, apoptotic and hormonal 
pathways involved in prostate tumourigenesis. Potentially, capsaicin could be an inexpensive and 
easily sourced dietary supplement to reduce the risk of prostate cancer.   
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